Sprint Bioscience AB (publ) (STO:SPRINT)
Sweden · Delayed Price · Currency is SEK 2.950
+0.060 (2.08%)
Apr 24, 2026, 5:29 PM CET
342.94% (1Y)
| Market Cap | 304.94M +535.7% |
| Revenue (ttm) | 167.17M +152.7% |
| Net Income | 91.74M |
| EPS | 0.98 |
| Shares Out | 105.52M |
| PE Ratio | 2.95 |
| Forward PE | 15.72 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 480,826 |
| Average Volume | 1,050,358 |
| Open | 2.870 |
| Previous Close | 2.890 |
| Day's Range | 2.670 - 3.000 |
| 52-Week Range | 0.360 - 4.140 |
| Beta | -0.72 |
| RSI | 50.77 |
| Earnings Date | May 8, 2026 |